- Tytuł:
- Tumor regression in cancer patients by very low doses of a T cell-engaging antibody.
- Autorzy:
- Źródło:
- Science (New York, N.Y.) [Science] 2008 Aug 15; Vol. 321 (5891), pp. 974-7.
- Typ publikacji:
- Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
- MeSH Terms:
-
Antibodies, Bispecific /*administration & dosage
Antineoplastic Agents/*administration & dosage
Lymphoma, B-Cell/*drug therapy
Lymphoma, Follicular/*drug therapy
Lymphoma, Mantle-Cell/*drug therapy
T-Lymphocytes, Cytotoxic/*immunologyAntibodies, Bispecific /adverse effects ;Antibodies, Bispecific /immunology ;Antibodies, Bispecific /therapeutic use ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; B-Lymphocytes/immunology ; Humans ; Immunologic Memory ; Immunophenotyping ; Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy ; Leukemia, Lymphocytic, Chronic, B-Cell/immunology ; Lymphocyte Count ; Lymphoma, B-Cell/immunology ; Lymphoma, Follicular/immunology ; Lymphoma, Mantle-Cell/immunology ; Recurrence ; T-Lymphocytes/immunology
Czasopismo naukowe